HES1 and central nervous system cancer: When the inhibitor was transfected into glioma cells, the expression levels of the Notch1, NICD, HES1 and HEY1 proteins in the inhibitor group were significantly higher than those in the inhibitor NC group (P < 0.05) (Fig. 4B,C).